Services and expertise

Consulting for Pharma develops solutions covering several areas of medicine commercialization including Strategy, CI, Market Access, HTAs, and P&R. These solutions are rooted in its experience from several years of cooperation with life science companies of all types, sizes, and sectors. Obtain a better understanding of Consulting for Pharma's services and expertise here.

Strategy

Whether short-term or long-term management planning, Consulting for Pharma's management expertise allows you to navigate the future of your company and its products with greater assurance. Interviews with industry Directors are conducted in order to gather Insights and for Evidence generation and Reports are compiled. Small, medium and large projects are carried out. Advice is given.

Competitive Intelligence

Comparison of rival companies and competitor products are key to maximising the profit from medicines and medical technology. Primary (interviews with Key Opinion Leaders, KOLs, and industry Directors) and secondary research and Congress coverage to gather Inisghts and for Evidence generation are undertaken in order to compile Strategic Benchmarking and War Gaming Reports. Medium-sized and large projects are carried out. 



Market Access and HTA

Due to increasing medicine cost-containment, a well-devised Market Access strategy is vital to influence Payers of the Value of a potential medicine or medical technology. Consulting for Pharma compiles comprehensive Health Technology Assessment/Appraisal (HTA) Submissions and Systems analysis Reports, healthcare Policy analysis Reports, and Market Access National and Global Value Dossiers comparing the proposed medicine or medical technology to those already marketed. Interviews with KOLs and Pharmacists are conducted in order to gather Insights and for Evidence generation. Market Access advice is given. Small, medium and large projects are carried out.



Pricing & Reimbursement

With many medicines and medical technologies on the market, a competitive price is increasingly important to achieve profit and obtain a Return on Investment in R&D. Pricing analysis is undertaken, and P&R advisory and analysis Reports and Submissions are prepared for life science companies and approval by Payers and pricing agencies. Interviews with Payers are conducted in order to gather Insights and for Evidence generation. P&R advice is also given. Small, medium, and large projects are carried out.

 

 

 

Contact and appointments

Please use the contact form for any questions or to make an appointment.